{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:33:30Z","timestamp":1789774410441,"version":"4.0.1"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.4103\/0973-1482.151945","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:48:49Z","timestamp":1455842929000},"page":"1041-1041","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Neoadjuvant chemotherapy with cetuximab for locally advanced penile cancer"],"prefix":"10.4103","volume":"11","author":[{"given":"Wu-Xia","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"He","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, West China Hospital, West China Medical School, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1470-2045(04)01427-5","article-title":"Penile carcinoma: A challenge for the developing World","volume":"5","author":"Misra","year":"2004","journal-title":"Lancet Oncol"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: A phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"e62175","DOI":"10.1371\/journal.pone.0062175","article-title":"Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma","volume":"8","author":"Gou","year":"2013","journal-title":"PLoS One"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2007.02.006","article-title":"Neoadjuvant chemotherapy in advanced penile carcinoma","volume":"52","author":"Leijte","year":"2007","journal-title":"Eur Urol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201511040-00166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:08Z","timestamp":1786647548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201511040-00166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":4,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-1482.151945","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}